Mechanisms of impaired fasting glucose and glucose intolerance induced by a-50% pancreatectomy

被引:57
作者
Matveyenko, Aleksey V.
Veldhuis, Johannes D.
Butler, Peter C.
机构
[1] Univ Calif Los Angeles, David Geffen Sch Med, Larry Hillblom Islet Res Ctr, Los Angeles, CA 90095 USA
[2] Mayo Clin, Mayo Med, Div Endocrine, Rochester, MN USA
[3] Mayo Clin, Grad Sch Med, Rochester, MN USA
关键词
D O I
10.2337/db06-0345
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Impaired fasting glucose (IFG) and impaired glucose tolerance (IGT) often coexist and as such represent a potent risk factor for subsequent development of type 2 diabetes. beta-Cell mass is similar to 50% deficient in IFG and similar to 65% deficient in type 2 diabetes. To establish the effect of a similar to 50% deficit in beta-cell mass on carbohydrate metabolism, we performed a similar to 50% partial pancreatectomy versus sham surgery in 14 dogs. Insulin secretion was quantified from insulin concentrations measured in the portal vein at 1-min sampling intervals under basal conditions, after a 30-g oral glucose, and during a hyperglycemic clamp. Insulin sensitivity was measured by a hyperinsulinemic-euglycemic clamp combined with isotope dilution. Partial pancreatectomy resulted in IFG and IGT. After partial pancreatectomy both basal and glucose-stimulated insulin secretion were decreased through the mechanism of a selective similar to 50 and similar to 80% deficit in insulin pulse mass, respectively (P < 0.05). These defects in insulin secretion were partially offset by decreased hepatic insulin clearance (P < 0.05). Partial pancreatectomy also caused a similar to 40% decrease in insulin-stimulated glucose disposal (P < 0.05), insulin sensitivity after partial pancreatectomy being related to insulin pulse amplitude (r = 0.9, P < .0.01). We conclude that a similar to 50% deficit in beta-cell mass can recapitulate the alterations in glucose-mediated insulin secretion and insulin action in humans with IFG and IGT. These data support a mechanistic role of a deficit in beta-cell mass in the evolution of IFG/IGT and subsequently type 2 diabetes.
引用
收藏
页码:2347 / 2356
页数:10
相关论文
共 42 条
  • [1] DECREASED HEPATIC INSULIN EXTRACTION IN SUBJECTS WITH MILD GLUCOSE-INTOLERANCE
    BONORA, E
    ZAVARONI, I
    COSCELLI, C
    BUTTURINI, U
    [J]. METABOLISM-CLINICAL AND EXPERIMENTAL, 1983, 32 (05): : 438 - 446
  • [2] β-cell deficit and increased β-cell apoptosis in humans with type 2 diabetes
    Butler, AE
    Janson, J
    Bonner-Weir, S
    Ritzel, R
    Rizza, RA
    Butler, PC
    [J]. DIABETES, 2003, 52 (01) : 102 - 110
  • [3] CONTRIBUTION TO POSTPRANDIAL HYPERGLYCEMIA AND EFFECT ON INITIAL SPLANCHNIC GLUCOSE CLEARANCE OF HEPATIC GLUCOSE CYCLING IN GLUCOSE-INTOLERANT OR NIDDM PATIENTS
    BUTLER, PC
    RIZZA, RA
    [J]. DIABETES, 1991, 40 (01) : 73 - 81
  • [4] METHODS FOR ASSESSMENT OF THE RATE OF ONSET AND OFFSET OF INSULIN ACTION DURING NONSTEADY STATE IN HUMANS
    BUTLER, PC
    CAUMO, A
    ZERMAN, A
    OBRIEN, PC
    COBELLI, C
    RIZZA, RA
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY, 1993, 264 (04): : E548 - E560
  • [5] HEPATIC AND EXTRAHEPATIC RESPONSES TO INSULIN IN NIDDM AND NONDIABETIC HUMANS - ASSESSMENT IN ABSENCE OF ARTIFACT INTRODUCED BY TRITIATED NONGLUCOSE CONTAMINANTS
    BUTLER, PC
    KRYSHAK, EJ
    SCHWENK, WF
    HAYMOND, MW
    RIZZA, RA
    [J]. DIABETES, 1990, 39 (02) : 217 - 225
  • [6] DEFRONZO RA, 1982, DIABETOLOGIA, V23, P313
  • [7] Metabolic abnormalities in impaired glucose tolerance
    Gerich, JE
    [J]. METABOLISM-CLINICAL AND EXPERIMENTAL, 1997, 46 (12): : 40 - 43
  • [8] DECREASED INSULIN-PULSE AND GLUCAGON-PULSE AMPLITUDE ACCOMPANYING BETA-CELL DEFICIENCY INDUCED BY STREPTOZOCIN IN BABOONS
    GOODNER, CJ
    KOERKER, DJ
    WEIGLE, DS
    MCCULLOCH, DK
    [J]. DIABETES, 1989, 38 (07) : 925 - 931
  • [9] INSULIN AND GLUCAGON-SECRETION AFTER PANCREATECTOMIES - CORRELATION OF SECRETION AND HORMONAL CONTENTS OF REMAINING PANCREAS
    GOTOH, M
    MONDEN, M
    OKAMURA, J
    MORI, T
    SHIMA, K
    [J]. DIABETES, 1989, 38 (07) : 861 - 867
  • [10] INSULIN ACTION, DIABETOGENES, AND THE CAUSE OF TYPE-II DIABETES
    KAHN, CR
    [J]. DIABETES, 1994, 43 (08) : 1066 - 1084